# Airway Clearance Study

> **NCT00379028** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 54 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Budesonide/Formoterol Turbuhaler
- **DRUG:** Salmeterol/Fluticasone Diskus

## Key facts

- **NCT ID:** NCT00379028
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379028, "Airway Clearance Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00379028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*